News

Article

In the Lab eNewsletter

Pharmaceutical Technology's In the Lab eNewsletter, September 2021
Volume16
Issue 09

BioAgilytix Acquires Australian-Based CRO 360biolabs

BioAgilytix, a US-based contract research laboratory focused on large-molecule drug development, has agreed to purchase 360biolabs, an Australia-based contract research organization specializing in virology and immunology.

BioAgilytix, a US-based contract research laboratory focused on large-molecule drug development, has agreed to purchase 360biolabs, an Australia-based contract research organization specializing in virology and immunology.

This agreement, signed on Aug. 16, 2021, will allow BioAgilytix to expand their first-in-human trial and early phase clinical trials into a new jurisdiction. Under the agreement, 360biolabs' facilities in Melbourne, Victoria, will be added to BioAgilytix’s existing laboratories in Durham, NC, Boston, Mass., and Hamburg, Germany.

The new facilities feature biosafety level 2 and three laboratories, a flow cytometry suite, a molecular biology polymerase chain reaction suite, and liquid chromatography–mass spectrometry/mass-spectrometry small-molecule capabilities.

"This planned acquisition is part of our strategic growth strategy to expand our capacity, expertise, and agility to serve customers across all geographies, and we look forward to welcoming the 360biolabs team and integrating the business," said Jim Datin, president and CEO of BioAgilytix, in a company press release. "Joining forces makes sense for our two organizations, but most importantly for our combined clients and the patients they serve. BioAgilytix and 360biolabs are already culturally aligned in our focus on doing science right, on time, the first time. Together, we will not only create significant scientific synergies but also generate new innovations and help bring future life-changing therapeutics to patients more rapidly around the globe."

Source: BioAgilytix

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Related Content